| | | | | |
AVTX Avalo Therapeutics, Inc. Common Stock | $15,9300 | -0,13 % | $838,42M | $980,32K | |
| $46,7700 | -0,47 % | $837,92M | $10,00 | |
| $23,2000 | -0,13 % | $836,70M | $1,000 | |
EVC Entravision Communication | $9,4872 | +4,48 % | $835,71M | $4,000 | |
ETON Eton Pharmaceutcials, Inc. Common Stock | $30,4600 | +0,03 % | $834,09M | $48,00 | |
| $27,2750 | -0,06 % | $832,22M | $211,00 | |
AMPH Amphastar Pharmaceuticals, Inc. | $18,8600 | +0,05 % | $831,15M | $1,000 | |
MATW Matthews International Corp | $26,5550 | +0,06 % | $828,11M | $1,000 | |
TBPH Theravance Biopharma, Inc. | $16,0600 | +0,00 % | $827,94M | $331,59K | |
MPB Mid Penn Bancorp, Inc. | $32,6100 | -0,12 % | $827,51M | $123,00 | |
KRO Kronos Worldwide, Inc. | $7,1900 | +0,00 % | $827,23M | $188,74K | |
ADAM Adamas Trust, Inc. Common Stock | $9,2000 | +0,00 % | $826,72M | $4,000 | |
CAPL CrossAmerica Partners LP Common units representing limited partner interests | $21,6200 | +0,00 % | $824,89M | $34,43K | |
ROOT Root, Inc. Class A Common Stock | $52,1000 | +0,08 % | $823,91M | $142,00 | |
EOI Eaton Vance Enhanced Equity Income Fund | $20,0800 | +0,00 % | $823,31M | $95,87K | |
